Wound Care News and Research

RSS

Blog explains why NeutroPhase can play important role in treating 'flesh-eating' infections

NovaBay Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, today announced that WoundSource™ has highlighted NovaBay's NeutroPhase wound cleanser in a recent blog posting. The blog explains why NeutroPhase can play an important role in treating life-threatening necrotizing fasciitis, or 'flesh-eating' infections.

21 Apr 2014

Researchers to develop cell-based approaches to minimize scarring in adult wounds

In early fetal development, skin wounds undergo regeneration and healing without scar formation. This mechanism of wound healing later disappears, but by studying the fetal stem cells capable of this scarless wound healing, researchers may be able to apply these mechanisms to develop cell-based approaches able to minimize scarring in adult wounds, as described in a Critical Review article published in Advances in Wound Care, a monthly publication from Mary Ann Liebert, Inc., publishers and an Official Journal of the Wound Healing Society.

11 Apr 2014

Osiris Therapeutics receives $15 million cash payment from Mesoblast for Prochymal

Osiris Therapeutics, Inc., the leading stem cell company focused on developing and marketing products to treat conditions in wound care, orthopedic and sports medicine markets, announced that it has received the next $15 million cash payment from Mesoblast in accordance with the Purchase Agreement relating to the Prochymal business.

9 Apr 2014

Rural nursing presents challenges, rewards

Providing comprehensive health care can be a daunting task for nurses serving nearly 60 million people living in rural America.

3 Apr 2014

Study finds that online ratings don't help patients to distinguish between hospitals

Despite having access to online ratings, patients can't distinguish the quality or performance of one hospital from another, finds a new study in Health Services Research.

19 Mar 2014

Derma Sciences' net sales increase 3% to $20.7 million in fourth quarter 2013

Derma Sciences, Inc., a tissue regeneration and burn care company focused on advanced wound care, today reported financial and operating results for the three months and year ended December 31, 2013.

14 Mar 2014

Procellera technology enhances cell migration in in-vitro laboratory testing

Procellera – the world's first wireless microcurrent generating dressing that produces electrical fields through its matrix of microcell batteries – was found to significantly enhance cell migration in in-vitro laboratory testing, according to groundbreaking research led by The Ohio State University Wexner Medical Center Professor Chandan K. Sen. Professor Sen is also the Director of the Comprehensive Wound Center at Ohio State.

4 Mar 2014

Polyurethane-based adhesive based on Bayer's Baymedix A raw material now available for wound care

Bayer MaterialScience LLC announces a polyurethane-based adhesive based on its Baymedix A raw material is now available in the United States.

13 Feb 2014

ACell releases new MatriStem Multilayer Wound Matrix device for hard-to-heal, full-thickness wounds

ACell, Inc., a leading regenerative medicine company focused on the development, manufacturing and commercialization of tissue repair products, today announced that it has launched the new MatriStem Multilayer Wound Matrix device for deep, hard-to-heal, full-thickness wounds.

10 Feb 2014

Sverica’s additional investment supports RestorixHealth's acquisition of Candescent Healing

Sverica International Management LLC, a private equity investment firm, announced today that it made an additional equity investment in RestorixHealth, a comprehensive wound care management company.

7 Jan 2014

A valuable guide for diabetic patients

McCord Research, Inc., founded by Darlene McCord, Ph.D., FAPWCA, has produced a valuable guide to help people with diabetes take care of their feet for a lifetime. Dr. McCord has over 30 years of experience in the skin and wound care industry. Ten years ago she also created the most successful skin and wound care product line in North America.

27 Dec 2013

Research review examines effectiveness of treatments for chronic skin wounds

A systematic review of 66 research papers focused on the treatment of skin ulcers suggests that most are so technically flawed that their results are unreliable. And even of those that pass muster, there is only weak evidence that some treatments work better than standard compression therapy or special stockings.

24 Dec 2013

‘Flesh-eating’ disease treatments: an interview with Dr. John Crew, Seton Medical Center

Untreated, the mortality probably exceeds 70%. Flesh eating is a description of Toxic Inflammatory Cellulitis which usually starts by bacterial subcutaneous infection followed by freezing in phase II healing which is inflammatory.

9 Dec 2013

Osiris: CMS releases proposed ruling for reimbursement of skin substitutes in hospital outpatient setting

Osiris Therapeutics, Inc., the leading stem cell company focused on developing and marketing products in orthopedics, sports medicine and wound care, announced today that, on November 27, 2013, the Centers for Medicare and Medicaid Services released their proposed ruling for the reimbursement of skin substitutes in the hospital outpatient setting. CMS decided to package the reimbursement for products used in advanced wound care with the related surgical procedure into a two-tier system.

30 Nov 2013

NeutroPhase irrigation therapy and NPWT help treat severe flesh eating and wound infections

NovaBay Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing topical non-antibiotic antimicrobial products, today announced the publication of a scientific paper by Dr. John R. Crew of Seton Medical Center, Daly City, California, describing the first use of adjunctive NeutroPhase irrigation therapy in conjunction with Negative Pressure Wound Therapy to successfully manage the severely-infected wound in the arm of a patient with life-threatening 'flesh-eating' disease.

20 Nov 2013

Kaiser Permanente to open doors to brand new specialty center in Lone Tree, Colorado

After years of planning, construction and preparation, Kaiser Permanente will open the doors to a brand new specialty center in Lone Tree on December 2nd. This is the largest construction project and the most significant addition to the health plan's brick-and-mortar presence in Colorado in nearly a decade.

15 Nov 2013

Wound Care News and Research

Blog explains why NeutroPhase can play important role in treating 'flesh-eating' infections

Researchers to develop cell-based approaches to minimize scarring in adult wounds

Osiris Therapeutics receives $15 million cash payment from Mesoblast for Prochymal

Rural nursing presents challenges, rewards

Study finds that online ratings don't help patients to distinguish between hospitals

Derma Sciences' net sales increase 3% to $20.7 million in fourth quarter 2013

Procellera technology enhances cell migration in in-vitro laboratory testing

Polyurethane-based adhesive based on Bayer's Baymedix A raw material now available for wound care

ACell releases new MatriStem Multilayer Wound Matrix device for hard-to-heal, full-thickness wounds

Sverica’s additional investment supports RestorixHealth's acquisition of Candescent Healing

A valuable guide for diabetic patients

Research review examines effectiveness of treatments for chronic skin wounds

‘Flesh-eating’ disease treatments: an interview with Dr. John Crew, Seton Medical Center

Osiris: CMS releases proposed ruling for reimbursement of skin substitutes in hospital outpatient setting

NeutroPhase irrigation therapy and NPWT help treat severe flesh eating and wound infections

Kaiser Permanente to open doors to brand new specialty center in Lone Tree, Colorado

Derma Sciences third quarter 2013 net sales increase 12% to $22.1 million

Covalon licenses antimicrobial silicone adhesive technology to Molnlycke Heath Care

MiMedx Group reports record revenue in third quarter 2013

Rates of hospital-acquired bedsores not accurate tool for comparing hospital quality, says report

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News